Protected: Tools and Resources
Welcome to our online tools and resources!
Below are different educational and promotional materials – something for everyone in our Family Heart ecosystem.
HeFH Brochure
HoFH Brochure
Lp(a) Brochure
Care Navigation Center Postcard
Care Navigation Center Flyer
What’s In My Family Tree?
Pediatric Testing Poster
Do you #knowFH
Heart Disease and Cholesterol
Familial Hypercholesterolemia
Homozygous Familial Hypercholesterolemia (HoFH)
Lipoprotein(a) Basics
Lipoprotein(a)
What to Expect: FH Treatments
What to Expect: HoFH Treatments
Lp(a) Testing
Research Infographics
CE Manuscript
HoFH in the US
Pediatric Diagnosis Missed
Patients Still Face Significant Challenges Accessing Life Saving Medicines
Lp(a) FAQ’s
Lp(a) Conversation with Family Members
FH Conversation with Family Members
Lp(a) Letter to Family
Lp(a) Letter to Family
Family Heart Ambassadors’ Stories
Family Heart Global Summit
More From Us
Since 2014, The Family Heart Foundation has published over 35 papers. These publications contribute to the evidence base and inform better screening, testing, diagnosis, and treatment of FH. They serve as tools for awareness and advocacy to advance our FH Global Call to Action recommendations.
Trends in Patient Access to and Utilization of Prescribed PCSK9 Inhibitors in a Large US Claims Database From 2015 to 2021
Optimizing Communication Strategies and Designing a Comprehensive Program to Facilitate Cascade Testing for Familial Hypercholesterolemia
Genetic Testing for Familial Hypercholesterolemia in Clinical Practice
Yield of Familial Hypercholesterolemia Genetic and Phenotypic Diagnosis After Electronic Health Record and Genomic Data Screening
Contemporary Homozygous Familial Hypercholesterolemia in the United States: Insights From the CASCADE FH Registry
USPSTF Recommendation on Screening for Lipid Disorders in Children and Adolescents (Wilemon, K, et al.)
USPSTF Recommendation on Screening for Lipid Disorders in Children and Adolescents (McGowan, M, et al.)
Motivating Cascade Testing for Familial Hypercholesterolemia: Applying the Extended Parallel Process Model for Clinician Communication
Patient Experiences Align with the Familial Hypercholesterolemia Global Call to Action
Acceptability, Appropriateness, and Feasibility of Automated Screening Approaches and Family Communication Methods for Identification of Familial Hypercholesterolemia: Stakeholder Engagement Results from the IMPACT-FH Study
Implementation of a Machine-Learning Algorithm in the Electronic Health Record for Targeted Screening for Familial Hypercholesterolemia
COVID-19 Associated Risks of Myocardial Infarction in Persons with Familial Hypercholesterolemia with or without ASCVD
Developing and Optimizing Innovative Tools to Address Familial Hypercholesterolemia Underdiagnosis: Identification Methods, Patient Activation, and Cascade Testing for Familial Hypercholesterolemia (IMPACT-FH)
A Proof-of-Concept Study of Cascade Screening for Familial Hypercholesterolemia in the US, Adapted from the Dutch Model.
Children with Heterozygous Familial Hypercholesterolemia in the United States Data from the Cascade Screening for Awareness and Detection-FH Registry
Women Living with Familial Hypercholesterolemia Challenges and Considerations Surrounding Their Care
Patient Acceptance of Genetic Testing for Familial Hypercholesterolemia in the CASCADE FH Registry
Perspectives from Individuals with Familial Hypercholesterolemia on Direct Contact in Cascade Screening
Reducing the Clinical Public Health Burden of Familial Hypercholesterolemia A Global Call to Action
Precision Screening for Familial Hypercholesterolemia: A Machine Learning Study Applied to Electronic Health Encounter Data
Effect of Access to Prescribed PCSK9 Inhibitors on Cardiovascular Outcomes
Finding Missed Cases of Familial Hypercholesterolemia in Health Systems Using Machine Learning
Longitudinal Low Density Lipoprotein Cholesterol Goal Achievement and Cardiovascular Outcomes Among Adult Patients with Familial Hypercholesterolemia
Familial Hypercholesterolemia Patient Determined Themes for Community Engaged Research
Clinical Genetic Testing for Familial Hypercholesterolemia
Delivery of Cascade Screening for Hereditary Conditions: A Scoping Review of the Literature
ClinVar Database of Global Familial Hypercholesterolemia Associated DNA Variants
Is Diet Management Helpful in Familial Hypercholesterolemia?
Familial Hypercholesterolemia Patient Support Groups and Advocacy: A Multinational Perspective
The Role of Registries and Genetic Databases in Familial Hypercholesterolemia
Access to Non-Statin Lipid Lowering Therapies in Patients at High Risk of Atherosclerotic Cardiovascular Disease
Health Disparities Among Adult Patients with a Phenotype Diagnosis of Familial Hypercholesterolemia in the CASCADE-FH Patient Registry
Cascade Screening for Familial Hypercholesterolemia and the Use of Genetic Testing
Treatment Gaps in Adults with Heterozygous Familial Hypercholesterolemia in the United States: Data from the CASCADE-FH Registry
Enough Evidence, Time to Act!
Statins in Familial Hypercholesterolemia – Translating Evidence to Action
US Physician Practices for diagnosing Familial Hypercholesterolemia: data from the CASCADE-FH Registry
Familial Hypercholesterolemia and the 2013 American College of Cardiology/American Heart Association Guidelines: Myths, Oversimplification and Misinterpretation versus Facts
Diagnosing Familial Hypercholesterolemia (FH) in the United States: Results from the CASCADE FH Patient Registry
The Rationale and Design of the CASCADE FH Registry
Initial Results from the CASCADE-FH Registry: CAscade Screening for Awareness and DEtection of Familial Hypercholesterolemia
Underutilization of Cascade Screening for Familial Hypercholesterolemia
Reducing the Burden of Disease and Death from Familial Hypercholesterolemia: A Call to Action
Rationale and Design of the Familial Hypercholesterolemia Foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia Registry
Familial Hypercholesterolemia in Rare Disease Database
Trends in Patient Access to and Utilization of Prescribed PCSK9 Inhibitors in a Large US Claims Database From 2015 to 2021
Optimizing Communication Strategies and Designing a Comprehensive Program to Facilitate Cascade Testing for Familial Hypercholesterolemia
Genetic Testing for Familial Hypercholesterolemia in Clinical Practice
Yield of Familial Hypercholesterolemia Genetic and Phenotypic Diagnosis After Electronic Health Record and Genomic Data Screening
Contemporary Homozygous Familial Hypercholesterolemia in the United States: Insights From the CASCADE FH Registry
USPSTF Recommendation on Screening for Lipid Disorders in Children and Adolescents (Wilemon, K, et al.)
USPSTF Recommendation on Screening for Lipid Disorders in Children and Adolescents (McGowan, M, et al.)
Motivating Cascade Testing for Familial Hypercholesterolemia: Applying the Extended Parallel Process Model for Clinician Communication
Patient Experiences Align with the Familial Hypercholesterolemia Global Call to Action
Acceptability, Appropriateness, and Feasibility of Automated Screening Approaches and Family Communication Methods for Identification of Familial Hypercholesterolemia: Stakeholder Engagement Results from the IMPACT-FH Study
Implementation of a Machine-Learning Algorithm in the Electronic Health Record for Targeted Screening for Familial Hypercholesterolemia
COVID-19 Associated Risks of Myocardial Infarction in Persons with Familial Hypercholesterolemia with or without ASCVD
Developing and Optimizing Innovative Tools to Address Familial Hypercholesterolemia Underdiagnosis: Identification Methods, Patient Activation, and Cascade Testing for Familial Hypercholesterolemia (IMPACT-FH)
A Proof-of-Concept Study of Cascade Screening for Familial Hypercholesterolemia in the US, Adapted from the Dutch Model.
Children with Heterozygous Familial Hypercholesterolemia in the United States Data from the Cascade Screening for Awareness and Detection-FH Registry
Women Living with Familial Hypercholesterolemia Challenges and Considerations Surrounding Their Care
Patient Acceptance of Genetic Testing for Familial Hypercholesterolemia in the CASCADE FH Registry
Perspectives from Individuals with Familial Hypercholesterolemia on Direct Contact in Cascade Screening
Reducing the Clinical Public Health Burden of Familial Hypercholesterolemia A Global Call to Action
Precision Screening for Familial Hypercholesterolemia: A Machine Learning Study Applied to Electronic Health Encounter Data
Effect of Access to Prescribed PCSK9 Inhibitors on Cardiovascular Outcomes
Finding Missed Cases of Familial Hypercholesterolemia in Health Systems Using Machine Learning
Longitudinal Low Density Lipoprotein Cholesterol Goal Achievement and Cardiovascular Outcomes Among Adult Patients with Familial Hypercholesterolemia
Familial Hypercholesterolemia Patient Determined Themes for Community Engaged Research
Clinical Genetic Testing for Familial Hypercholesterolemia
Delivery of Cascade Screening for Hereditary Conditions: A Scoping Review of the Literature
ClinVar Database of Global Familial Hypercholesterolemia Associated DNA Variants
Is Diet Management Helpful in Familial Hypercholesterolemia?
Familial Hypercholesterolemia Patient Support Groups and Advocacy: A Multinational Perspective
The Role of Registries and Genetic Databases in Familial Hypercholesterolemia
Access to Non-Statin Lipid Lowering Therapies in Patients at High Risk of Atherosclerotic Cardiovascular Disease
Health Disparities Among Adult Patients with a Phenotype Diagnosis of Familial Hypercholesterolemia in the CASCADE-FH Patient Registry
Cascade Screening for Familial Hypercholesterolemia and the Use of Genetic Testing
Treatment Gaps in Adults with Heterozygous Familial Hypercholesterolemia in the United States: Data from the CASCADE-FH Registry
Enough Evidence, Time to Act!
Statins in Familial Hypercholesterolemia – Translating Evidence to Action
US Physician Practices for diagnosing Familial Hypercholesterolemia: data from the CASCADE-FH Registry
Familial Hypercholesterolemia and the 2013 American College of Cardiology/American Heart Association Guidelines: Myths, Oversimplification and Misinterpretation versus Facts
Diagnosing Familial Hypercholesterolemia (FH) in the United States: Results from the CASCADE FH Patient Registry
The Rationale and Design of the CASCADE FH Registry
Initial Results from the CASCADE-FH Registry: CAscade Screening for Awareness and DEtection of Familial Hypercholesterolemia
Underutilization of Cascade Screening for Familial Hypercholesterolemia
Reducing the Burden of Disease and Death from Familial Hypercholesterolemia: A Call to Action
Rationale and Design of the Familial Hypercholesterolemia Foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia Registry
Familial Hypercholesterolemia in Rare Disease Database
Coming Soon!
72% of High-Risk Hypercholesterolemia Patients Never Reach Below ACC/AHA Guideline LDL-C Thresholds.
Higher Cardiovascular Events Rates for High-Risk Americans Who Do Not Meet 2018 Multidisciplinary Guideline on the Management of Blood Cholesterol
The Vast Majority of Hypercholesterolemia Patients Never Reach Below LDL-C Thresholds in the 2018 ACC/AHA Guideline
Higher Cardiovascular Event Rates for Americans Who Do Not Meet 2018 Multidisciplinary Guideline on the Management of Blood Cholesterol Thresholds
Characterization of Children with Homozygous Familial Hypercholesterolemia from the CASCADE FH Registry
Using Healthcare Claims Data and Machine Learning to Identify Health Disparities for Individuals with Diagnosed and Undiagnosed Familial Hypercholesterolemia
Diagnosis of Familial Hypercholesterolemia: A Work in Progress
Characterization of Lp(a) Measurement in a Large U.S. Health Care Dataset
#1187 Real World Observational Study of Elevated Lp(a) and Cardiovascular Events
Engaging Individuals with Familial Hypercholesterolemia and their Families to Design a Direct Contact Program (DCP) to Improve CASCADE Testing Uptake
A Complex Rearrangement in the LDLR Gene in a Patient with Familial Hypercholesterolemia and Severe Coronary Artery Disease
Validation of Flag, Identify, Network, Deliver: FIND FH® Using the Electronic Medical Record to Identify Familial Hypercholesterolemia within a Single Healthcare System
Familial Hypercholesterolemia Patients Response to a Free Genetic Testing Offer
Implementation of Flag, Identify, Network, Deliver: FIND FH® Using the Electronic Medical Record to Identify Familial Hypercholesterolemia within a Single Healthcare System
Homozygous Familial Hypercholesterolemia in the United States Data from the CASCADE FH Registry
Cost-effectiveness of Screening and Management Strategies for Familial Hypercholesterolemia in the United States: an Update
Health Disparities among Adult Patients with Familial Hypercholesterolemia in the CASCADE FH Patient Registry
Improved Longitudinal LDL C Goal Achievement Among Familial Hypercholesterolemia Patients in the CASCADE FH Registry
Pediatric Familial Hypercholesterolemia: Children and Adolescents Enrolled in the CAscade SCreening for Awareness and DEtection FH Registry
Diagnosing Familial Hypercholesterolemia (FH) in the US: Results From the CASCADE FH Patient Registry
Initial Results from the CASCADE FH Registry: CAscade Screening for Awareness and Detection of Familial Hypercholesterolemia
Understanding Family Heart Disease
LDL Cholesterol
Find A Specialist
Familial Hypercholesterolemia
Homozygous Familial Hypercholesterolemia
Lipoprotein(a)
Reading Your Lipid and Lipoprotein(a) Test Results
Lowering Your High LDL Cholesterol
Care Navigation Center
How to Treat Homozygous Familial Hypercholesterolemia
How to Treat High Lipoprotein(a)
How to Treat Familial Hypercholesterolemia
Support Groups
Eating Healthy
